Generic Name: reslizumab
Brand Name: Cinqair
Manufacturer: TEVA Canada Innovation
Indications: Asthma, eosinophilic
Manufacturer Requested Reimbursement Criteria1: Not applicable
Submission Type: Request For Advice
Project Status: Received
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.